Home » Topics » Regulatory » Patents

Patents
RSS

GnRH antagonists for sex hormone-related disorders described by Takeda

April 24, 1998

Nippon Kayaku discloses new antiproliferative compound produced by bacterial species

April 24, 1998

Chugai synthesizes prokinetic erythromycins

April 23, 1998

Suntory researchers discover new treatments for convulsions, ischemia

April 23, 1998

Potent and selective anti-H. pylori agents in the pipeline at Zenyaku Kogyo

April 23, 1998

Gelatinase inhibitor with antitumor activity disclosed by Banyu

April 23, 1998

New azole antifungals developed at Takeda

April 23, 1998

New tryptase inhibitors from Arris

April 23, 1998

Roche discloses antiproliferative substituted pyrroles

April 23, 1998

New immunosuppressants from Procept

April 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.